Elizabeth Arden 2007 results
This article was originally published in The Rose Sheet
Executive SummaryFirm records $1.128 bil. in sales for FY 2007, up 18% from 2006. Net fourth-quarter sales increased 28% to $242.7 mil., driven by a 51% increase in firm's U.S. mass business and a 27% increase in its U.S. Elizabeth Arden Department store business. International business increased 12% during the Q4, with strong performances from Britney Spears fragrances, according to Arden. Total fragrance sales in North America soared 40% in Q4 and 23% for the full year, with gains primarily in the mass channel. North American fragrance store and department store business was down 6% in 2007, Arden notes. "The key accomplishment for fiscal 2007 year was ... the Elizabeth Arden brand itself - it grew16 percent," Chairman, President and CEO E. Scott Beattie remarked during Aug. 16 call. The Prevage brand advanced more than 45% in 2007, with especially strong growth in travel retail in Asia. Arden plans to launch M by Mariah Carey worldwide in early September, followed by Britney Spears Believe later that month...
You may also be interested in...
Tschudin talked to Scrip about taking over as Novartis Pharmaceuticals president, why inclisiran is different from marketed PCSK9 inhibitors and prioritizing investment behind multiple new launches.
Agency hasn't named the celebrity that will participate in the study on the impact that celebrity and non-celebrity endorsements have on consumer perceptions about Rx drugs.
Chronicle of the development and review of Sarepta’s golodirsen for treatment of Duchenne muscular dystrophy patients with a genetic mutation amenable to exon 53 skipping.